Semen cryobanking for men with cancer - Criteria change

W. G. Sanger, J. H. Olson, J. K. Sherman

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Objective: To summarize pregnancies and births after the use of pretherapy cryobanked semen from men with cancer and to reassess the clinical role of semen cryobanking for these patients. Design: Survey of pregnancies and births that have occurred after the use of cryobanked semen from pretherapy cancer patients. Setting: Survey of the literature and of nine semen banks. Patients: Men with testicular cancer, Hodgkin's diseases, non-Hodgkin's lymphoma, and other types of cancer who cryobanked their semen specimens before therapy. Outcome Measures: Pregnancies and births resulting from the use of cryobanked semen after artificial insemination by husband (AIH) or other assisted reproductive technology (ART) procedures. Results: The use of AIH and other ART procedures have resulted in 117 documented pregnancies and 115 livebirths. Conclusions: Cryobanking of semen should be offered to all men diagnosed with cancer because such a procedure provides the only reasonable chance of establishing a pregnancy after therapy that is detrimental to fertility potential. Existing criteria for pretherapy semen cryobanking, therefore, should be revised in view of successful pregnancies even with the use of semen with low spermatozoal densities and motilities, as well as other realized clinical efficacies of ART. Conceptions have occurred after in vitro fertilization (IVF) with <1 x 106 motile spermatozoa. Semen cryobanking should be offered by the attending physician as a viable option for any pretherapy male patient who has any motile sperm and considers the future possibility of having children.

Original languageEnglish (US)
Pages (from-to)1024-1027
Number of pages4
JournalFertility and Sterility
Volume58
Issue number5
DOIs
StatePublished - Jan 1 1992

Fingerprint

Semen
Neoplasms
Pregnancy
Assisted Reproductive Techniques
Insemination, Artificial, Homologous
Parturition
Spermatozoa
Testicular Neoplasms
Fertilization in Vitro
Hodgkin Disease
Non-Hodgkin's Lymphoma
Fertility
Outcome Assessment (Health Care)
Physicians
Therapeutics

Keywords

  • Semen cryobanking
  • artificial insemination
  • assisted reproductive technologies
  • cancer therapy

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Semen cryobanking for men with cancer - Criteria change. / Sanger, W. G.; Olson, J. H.; Sherman, J. K.

In: Fertility and Sterility, Vol. 58, No. 5, 01.01.1992, p. 1024-1027.

Research output: Contribution to journalArticle

Sanger, W. G. ; Olson, J. H. ; Sherman, J. K. / Semen cryobanking for men with cancer - Criteria change. In: Fertility and Sterility. 1992 ; Vol. 58, No. 5. pp. 1024-1027.
@article{b0d14ce09e4a46c2a1e0f40f4b098dcc,
title = "Semen cryobanking for men with cancer - Criteria change",
abstract = "Objective: To summarize pregnancies and births after the use of pretherapy cryobanked semen from men with cancer and to reassess the clinical role of semen cryobanking for these patients. Design: Survey of pregnancies and births that have occurred after the use of cryobanked semen from pretherapy cancer patients. Setting: Survey of the literature and of nine semen banks. Patients: Men with testicular cancer, Hodgkin's diseases, non-Hodgkin's lymphoma, and other types of cancer who cryobanked their semen specimens before therapy. Outcome Measures: Pregnancies and births resulting from the use of cryobanked semen after artificial insemination by husband (AIH) or other assisted reproductive technology (ART) procedures. Results: The use of AIH and other ART procedures have resulted in 117 documented pregnancies and 115 livebirths. Conclusions: Cryobanking of semen should be offered to all men diagnosed with cancer because such a procedure provides the only reasonable chance of establishing a pregnancy after therapy that is detrimental to fertility potential. Existing criteria for pretherapy semen cryobanking, therefore, should be revised in view of successful pregnancies even with the use of semen with low spermatozoal densities and motilities, as well as other realized clinical efficacies of ART. Conceptions have occurred after in vitro fertilization (IVF) with <1 x 106 motile spermatozoa. Semen cryobanking should be offered by the attending physician as a viable option for any pretherapy male patient who has any motile sperm and considers the future possibility of having children.",
keywords = "Semen cryobanking, artificial insemination, assisted reproductive technologies, cancer therapy",
author = "Sanger, {W. G.} and Olson, {J. H.} and Sherman, {J. K.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/S0015-0282(16)55454-5",
language = "English (US)",
volume = "58",
pages = "1024--1027",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Semen cryobanking for men with cancer - Criteria change

AU - Sanger, W. G.

AU - Olson, J. H.

AU - Sherman, J. K.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Objective: To summarize pregnancies and births after the use of pretherapy cryobanked semen from men with cancer and to reassess the clinical role of semen cryobanking for these patients. Design: Survey of pregnancies and births that have occurred after the use of cryobanked semen from pretherapy cancer patients. Setting: Survey of the literature and of nine semen banks. Patients: Men with testicular cancer, Hodgkin's diseases, non-Hodgkin's lymphoma, and other types of cancer who cryobanked their semen specimens before therapy. Outcome Measures: Pregnancies and births resulting from the use of cryobanked semen after artificial insemination by husband (AIH) or other assisted reproductive technology (ART) procedures. Results: The use of AIH and other ART procedures have resulted in 117 documented pregnancies and 115 livebirths. Conclusions: Cryobanking of semen should be offered to all men diagnosed with cancer because such a procedure provides the only reasonable chance of establishing a pregnancy after therapy that is detrimental to fertility potential. Existing criteria for pretherapy semen cryobanking, therefore, should be revised in view of successful pregnancies even with the use of semen with low spermatozoal densities and motilities, as well as other realized clinical efficacies of ART. Conceptions have occurred after in vitro fertilization (IVF) with <1 x 106 motile spermatozoa. Semen cryobanking should be offered by the attending physician as a viable option for any pretherapy male patient who has any motile sperm and considers the future possibility of having children.

AB - Objective: To summarize pregnancies and births after the use of pretherapy cryobanked semen from men with cancer and to reassess the clinical role of semen cryobanking for these patients. Design: Survey of pregnancies and births that have occurred after the use of cryobanked semen from pretherapy cancer patients. Setting: Survey of the literature and of nine semen banks. Patients: Men with testicular cancer, Hodgkin's diseases, non-Hodgkin's lymphoma, and other types of cancer who cryobanked their semen specimens before therapy. Outcome Measures: Pregnancies and births resulting from the use of cryobanked semen after artificial insemination by husband (AIH) or other assisted reproductive technology (ART) procedures. Results: The use of AIH and other ART procedures have resulted in 117 documented pregnancies and 115 livebirths. Conclusions: Cryobanking of semen should be offered to all men diagnosed with cancer because such a procedure provides the only reasonable chance of establishing a pregnancy after therapy that is detrimental to fertility potential. Existing criteria for pretherapy semen cryobanking, therefore, should be revised in view of successful pregnancies even with the use of semen with low spermatozoal densities and motilities, as well as other realized clinical efficacies of ART. Conceptions have occurred after in vitro fertilization (IVF) with <1 x 106 motile spermatozoa. Semen cryobanking should be offered by the attending physician as a viable option for any pretherapy male patient who has any motile sperm and considers the future possibility of having children.

KW - Semen cryobanking

KW - artificial insemination

KW - assisted reproductive technologies

KW - cancer therapy

UR - http://www.scopus.com/inward/record.url?scp=0026452191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026452191&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(16)55454-5

DO - 10.1016/S0015-0282(16)55454-5

M3 - Article

C2 - 1426353

AN - SCOPUS:0026452191

VL - 58

SP - 1024

EP - 1027

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -